Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1993 Jul;68(1):86–92. doi: 10.1038/bjc.1993.291

Response to adjuvant chemotherapy in primary breast cancer: no correlation with expression of glutathione S-transferases.

W H Peters 1, H M Roelofs 1, W L van Putten 1, J B Jansen 1, J G Klijn 1, J A Foekens 1
PMCID: PMC1968285  PMID: 8318426

Abstract

Of 139 node-positive breast cancer patients treated with adjuvant chemotherapy, the pre-treatment levels of glutathione S-transferase (GST) classes alpha, mu and pi, were determined by immuno-quantification on Western blots in cytosols of the primary tumours. Their expression was studied with respect to cytosolic oestrogen-receptor, progesterone-receptor and cathepsin D levels, and to the length of disease-free survival. GST class pi was negatively correlated with oestrogen receptor and progesterone receptor, and positively correlated with cathepsin D. There was no correlation between GST isoenzymes and the length of disease-free survival. These data suggest that glutathione S-transferases are not useful as markers to predict the response to adjuvant chemotherapy in human breast cancer.

Full text

PDF
86

Images in this article

87Figure 1
on p.87

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bolton M. G., Colvin O. M., Hilton J. Specificity of isozymes of murine hepatic glutathione S-transferase for the conjugation of glutathione with L-phenylalanine mustard. Cancer Res. 1991 May 1;51(9):2410–2415. [PubMed] [Google Scholar]
  2. Campbell J. A., Corrigall A. V., Guy A., Kirsch R. E. Immunohistologic localization of alpha, mu, and pi class glutathione S-transferases in human tissues. Cancer. 1991 Mar 15;67(6):1608–1613. doi: 10.1002/1097-0142(19910315)67:6<1608::aid-cncr2820670623>3.0.co;2-s. [DOI] [PubMed] [Google Scholar]
  3. Cazenave L. A., Moscow J. A., Myers C. E., Cowan K. H. Glutathione S-transferase and drug resistance. Cancer Treat Res. 1989;48:171–187. doi: 10.1007/978-1-4613-1601-5_11. [DOI] [PubMed] [Google Scholar]
  4. Ciaccio P. J., Tew K. D., LaCreta F. P. Enzymatic conjugation of chlorambucil with glutathione by human glutathione S-transferases and inhibition by ethacrynic acid. Biochem Pharmacol. 1991 Sep 12;42(7):1504–1507. doi: 10.1016/0006-2952(91)90468-k. [DOI] [PubMed] [Google Scholar]
  5. Cowan K. H., Batist G., Tulpule A., Sinha B. K., Myers C. E. Similar biochemical changes associated with multidrug resistance in human breast cancer cells and carcinogen-induced resistance to xenobiotics in rats. Proc Natl Acad Sci U S A. 1986 Dec;83(24):9328–9332. doi: 10.1073/pnas.83.24.9328. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Dulik D. M., Fenselau C., Hilton J. Characterization of melphalan-glutathione adducts whose formation is catalyzed by glutathione transferases. Biochem Pharmacol. 1986 Oct 1;35(19):3405–3409. doi: 10.1016/0006-2952(86)90444-2. [DOI] [PubMed] [Google Scholar]
  7. Foekens J. A., Portengen H., van Putten W. L., Peters H. A., Krijnen H. L., Alexieva-Figusch J., Klijn J. G. Prognostic value of estrogen and progesterone receptors measured by enzyme immunoassays in human breast tumor cytosols. Cancer Res. 1989 Nov 1;49(21):5823–5828. [PubMed] [Google Scholar]
  8. Foekens J. A., Portengen H., van Putten W. L., Trapman A. M., Reubi J. C., Alexieva-Figusch J., Klijn J. G. Prognostic value of receptors for insulin-like growth factor 1, somatostatin, and epidermal growth factor in human breast cancer. Cancer Res. 1989 Dec 15;49(24 Pt 1):7002–7009. [PubMed] [Google Scholar]
  9. Forrester L. M., Hayes J. D., Millis R., Barnes D., Harris A. L., Schlager J. J., Powis G., Wolf C. R. Expression of glutathione S-transferases and cytochrome P450 in normal and tumor breast tissue. Carcinogenesis. 1990 Dec;11(12):2163–2170. doi: 10.1093/carcin/11.12.2163. [DOI] [PubMed] [Google Scholar]
  10. Howie A. F., Forrester L. M., Glancey M. J., Schlager J. J., Powis G., Beckett G. J., Hayes J. D., Wolf C. R. Glutathione S-transferase and glutathione peroxidase expression in normal and tumour human tissues. Carcinogenesis. 1990 Mar;11(3):451–458. doi: 10.1093/carcin/11.3.451. [DOI] [PubMed] [Google Scholar]
  11. Howie A. F., Miller W. R., Hawkins R. A., Hutchinson A. R., Beckett G. J. Expression of glutathione S-transferase B1, B2, Mu and Pi in breast cancers and their relationship to oestrogen receptor status. Br J Cancer. 1989 Dec;60(6):834–837. doi: 10.1038/bjc.1989.375. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Kantor R. R., Giardina S. L., Bartolazzi A., Townsend A. J., Myers C. E., Cowan K. H., Longo D. L., Natali P. G. Monoclonal antibodies to glutathione S-transferase pi-immunohistochemical analysis of human tissues and cancers. Int J Cancer. 1991 Jan 21;47(2):193–201. doi: 10.1002/ijc.2910470206. [DOI] [PubMed] [Google Scholar]
  13. Keith W. N., Stallard S., Brown R. Expression of mdr1 and gst-pi in human breast tumours: comparison to in vitro chemosensitivity. Br J Cancer. 1990 May;61(5):712–716. doi: 10.1038/bjc.1990.160. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Mannervik B., Danielson U. H. Glutathione transferases--structure and catalytic activity. CRC Crit Rev Biochem. 1988;23(3):283–337. doi: 10.3109/10409238809088226. [DOI] [PubMed] [Google Scholar]
  15. Moscow J. A., Townsend A. J., Goldsmith M. E., Whang-Peng J., Vickers P. J., Poisson R., Legault-Poisson S., Myers C. E., Cowan K. H. Isolation of the human anionic glutathione S-transferase cDNA and the relation of its gene expression to estrogen-receptor content in primary breast cancer. Proc Natl Acad Sci U S A. 1988 Sep;85(17):6518–6522. doi: 10.1073/pnas.85.17.6518. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Murphy D., McGown A. T., Hall A., Cattan A., Crowther D., Fox B. W. Glutathione S-transferase activity and isoenzyme distribution in ovarian tumour biopsies taken before or after cytotoxic chemotherapy. Br J Cancer. 1992 Nov;66(5):937–942. doi: 10.1038/bjc.1992.389. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Namer M., Ramaioli A., Fontana X., Etienne M. C., Héry M., Jourlait A., Milano G., Frenay M., François E., Lapalus F. Prognostic value of total cathepsin D in breast tumors. A possible role in selection of chemoresistant patients. Breast Cancer Res Treat. 1991 Oct;19(2):85–93. doi: 10.1007/BF01980938. [DOI] [PubMed] [Google Scholar]
  18. Peters W. H., Boon C. E., Roelofs H. M., Wobbes T., Nagengast F. M., Kremers P. G. Expression of drug-metabolizing enzymes and P-170 glycoprotein in colorectal carcinoma and normal mucosa. Gastroenterology. 1992 Aug;103(2):448–455. doi: 10.1016/0016-5085(92)90833-k. [DOI] [PubMed] [Google Scholar]
  19. Peters W. H., Jansen P. L. Immunocharacterization of UDP-glucuronyltransferase isoenzymes in human liver, intestine and kidney. Biochem Pharmacol. 1988 Feb 1;37(3):564–567. doi: 10.1016/0006-2952(88)90234-1. [DOI] [PubMed] [Google Scholar]
  20. Peters W. H., Kock L., Nagengast F. M., Roelofs H. M. Immunodetection with a monoclonal antibody of glutathione S-transferase mu in patients with and without carcinomas. Biochem Pharmacol. 1990 Feb 1;39(3):591–597. doi: 10.1016/0006-2952(90)90068-v. [DOI] [PubMed] [Google Scholar]
  21. Peters W. H., Nagengast F. M., Wobbes T. Glutathione S-transferases in normal and cancerous human colon tissue. Carcinogenesis. 1989 Dec;10(12):2371–2374. doi: 10.1093/carcin/10.12.2371. [DOI] [PubMed] [Google Scholar]
  22. Peters W. H., Wormskamp N. G., Thies E. Expression of glutathione S-transferases in normal gastric mucosa and in gastric tumors. Carcinogenesis. 1990 Sep;11(9):1593–1596. doi: 10.1093/carcin/11.9.1593. [DOI] [PubMed] [Google Scholar]
  23. Rochefort H. Cathepsin D in breast cancer: a tissue marker associated with metastasis. Eur J Cancer. 1992;28A(11):1780–1783. doi: 10.1016/0959-8049(92)90003-k. [DOI] [PubMed] [Google Scholar]
  24. Seidegård J., Pero R. W., Markowitz M. M., Roush G., Miller D. G., Beattie E. J. Isoenzyme(s) of glutathione transferase (class Mu) as a marker for the susceptibility to lung cancer: a follow up study. Carcinogenesis. 1990 Jan;11(1):33–36. doi: 10.1093/carcin/11.1.33. [DOI] [PubMed] [Google Scholar]
  25. Shea T. C., Claflin G., Comstock K. E., Sanderson B. J., Burstein N. A., Keenan E. J., Mannervik B., Henner W. D. Glutathione transferase activity and isoenzyme composition in primary human breast cancers. Cancer Res. 1990 Nov 1;50(21):6848–6853. [PubMed] [Google Scholar]
  26. Terrier P., Townsend A. J., Coindre J. M., Triche T. J., Cowan K. H. An immunohistochemical study of pi class glutathione S-transferase expression in normal human tissue. Am J Pathol. 1990 Oct;137(4):845–853. [PMC free article] [PubMed] [Google Scholar]
  27. Tsuchida S., Sato K. Glutathione transferases and cancer. Crit Rev Biochem Mol Biol. 1992;27(4-5):337–384. doi: 10.3109/10409239209082566. [DOI] [PubMed] [Google Scholar]
  28. Vos R. M., Van Bladeren P. J. Glutathione S-transferases in relation to their role in the biotransformation of xenobiotics. Chem Biol Interact. 1990;75(3):241–265. doi: 10.1016/0009-2797(90)90069-y. [DOI] [PubMed] [Google Scholar]
  29. Waxman D. J. Glutathione S-transferases: role in alkylating agent resistance and possible target for modulation chemotherapy--a review. Cancer Res. 1990 Oct 15;50(20):6449–6454. [PubMed] [Google Scholar]
  30. Wiencke J. K., Kelsey K. T., Lamela R. A., Toscano W. A., Jr Human glutathione S-transferase deficiency as a marker of susceptibility to epoxide-induced cytogenetic damage. Cancer Res. 1990 Mar 1;50(5):1585–1590. [PubMed] [Google Scholar]
  31. Wolf C. R., Macpherson J. S., Smyth J. F. Evidence for the metabolism of mitozantrone by microsomal glutathione transferases and 3-methylcholanthrene-inducible glucuronosyl transferases. Biochem Pharmacol. 1986 May 1;35(9):1577–1581. doi: 10.1016/0006-2952(86)90127-9. [DOI] [PubMed] [Google Scholar]
  32. Wright C., Cairns J., Cantwell B. J., Cattan A. R., Hall A. G., Harris A. L., Horne C. H. Response to mitoxantrone in advanced breast cancer: correlation with expression of c-erbB-2 protein and glutathione S-transferases. Br J Cancer. 1992 Feb;65(2):271–274. doi: 10.1038/bjc.1992.54. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Yuan Z. M., Smith P. B., Brundrett R. B., Colvin M., Fenselau C. Glutathione conjugation with phosphoramide mustard and cyclophosphamide. A mechanistic study using tandem mass spectrometry. Drug Metab Dispos. 1991 May-Jun;19(3):625–629. [PubMed] [Google Scholar]
  34. van Poppel G., de Vogel N., van Balderen P. J., Kok F. J. Increased cytogenetic damage in smokers deficient in glutathione S-transferase isozyme mu. Carcinogenesis. 1992 Feb;13(2):303–305. doi: 10.1093/carcin/13.2.303. [DOI] [PubMed] [Google Scholar]
  35. van der Zee A. G., van Ommen B., Meijer C., Hollema H., van Bladeren P. J., de Vries E. G. Glutathione S-transferase activity and isoenzyme composition in benign ovarian tumours, untreated malignant ovarian tumours, and malignant ovarian tumours after platinum/cyclophosphamide chemotherapy. Br J Cancer. 1992 Nov;66(5):930–936. doi: 10.1038/bjc.1992.388. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES